2023 NICE 技术鉴定指导意见：奥拉帕尼用于既往治疗过的 BRCA 突变阳性激素复发转移性前列腺癌[TA887].pdfVIP

Olaparibforpreviously

treatedBRCAmutation-

positivehormone-relapsed

metastaticprostatecancer

Technologyappraisalguidance

Published:10May2023

.uk/guidance/ta887

©NICE2023.Allrightsreserved.SubjecttoNoticeofrights(.uk/terms-and-

conditions#notice-of-rights).

OlaparibforpreviouslytreatedBRCAmutation-positivehormone-relapsedmetastatic

prostatecancer(TA887)

Yourresponsibility

TherecommendationsinthisguidancerepresenttheviewofNICE,arrivedataftercareful

considerationoftheevidenceavailable.Whenexercisingtheirjudgement,health

pro